Oscar Health, Inc. (NYSE:OSCR) Given Average Rating of “Moderate Buy” by Brokerages

Oscar Health, Inc. (NYSE:OSCR) has earned an average recommendation of “Moderate Buy” from the six research firms that are currently covering the stock, Marketbeat reports. Two equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The average 1-year target price among brokerages that have issued a report on the stock in the last year is $13.50.

Several analysts have commented on OSCR shares. TheStreet raised shares of Oscar Health from a “d” rating to a “c-” rating in a research report on Wednesday, February 21st. The Goldman Sachs Group increased their target price on shares of Oscar Health from $8.00 to $16.00 and gave the company a “neutral” rating in a research report on Friday, February 9th. Raymond James started coverage on shares of Oscar Health in a report on Friday, March 22nd. They issued an “outperform” rating and a $20.00 price target on the stock. Finally, Wells Fargo & Company increased their price objective on Oscar Health from $12.00 to $20.00 and gave the company an “overweight” rating in a report on Thursday, February 15th.

Oscar Health Trading Up 5.2 %

NYSE OSCR opened at $18.97 on Tuesday. Oscar Health has a one year low of $4.72 and a one year high of $19.04. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.19 and a current ratio of 1.19. The company has a market capitalization of $4.36 billion, a price-to-earnings ratio of -15.80 and a beta of 1.66. The company’s 50-day simple moving average is $15.30 and its two-hundred day simple moving average is $11.76.

Oscar Health (NYSE:OSCR) last released its quarterly earnings data on Wednesday, February 7th. The company reported ($0.66) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.74) by $0.08. The firm had revenue of $1.43 billion for the quarter, compared to the consensus estimate of $1.43 billion. Oscar Health had a negative net margin of 4.62% and a negative return on equity of 29.99%. The company’s quarterly revenue was up 43.9% on a year-over-year basis. During the same period last year, the firm earned ($1.05) earnings per share. Equities analysts forecast that Oscar Health will post -0.23 EPS for the current fiscal year.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of the company. Precision Wealth Strategies LLC acquired a new position in Oscar Health in the 3rd quarter worth approximately $60,000. SG Americas Securities LLC purchased a new stake in shares of Oscar Health in the 3rd quarter valued at $62,000. Brown Advisory Inc. acquired a new stake in shares of Oscar Health in the third quarter worth $83,000. Amalgamated Bank raised its holdings in shares of Oscar Health by 10.6% during the third quarter. Amalgamated Bank now owns 15,762 shares of the company’s stock worth $88,000 after purchasing an additional 1,516 shares during the last quarter. Finally, Prevail Innovative Wealth Advisors LLC purchased a new position in shares of Oscar Health during the fourth quarter worth $92,000. 75.70% of the stock is currently owned by hedge funds and other institutional investors.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.